Spectral Medical Provides Clinical and Regulatory Update
- Trial enrolment is 90% complete - Company is on track to submit for FDA market approval in H2 2016 TORONTO, ONTARIO -- (Marketwired) -- 01/11/16 -- Spectral Medical Inc., ("Spectral" or the "Company") (TSX: EDT)(OTCQX: EDTXF), a Phase …